Market closed

Hologic/$HOLX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Hologic

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Ticker

$HOLX
Trading on

Industry

Health Care Equipment & Supplies

Employees

6,990

Hologic Metrics

BasicAdvanced
$18B
Market cap
26.77
P/E ratio
$2.92
EPS
0.98
Beta
-
Dividend rate
$18B
0.98
$84.67
$67.59
1.6M
3.987
3.06
50.609
51.366
8.01%
6.45%
13.85%
26.772
4.669
3.7
18.83
18.351
-1.26%
49.92%
-11.03%
-27.99%

What the Analysts think about Hologic

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Hologic stock.

Hologic Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Hologic Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HOLX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Hologic stock?

Hologic (HOLX) has a market cap of $18B as of November 21, 2024.

What is the P/E ratio for Hologic stock?

The price to earnings (P/E) ratio for Hologic (HOLX) stock is 26.77 as of November 21, 2024.

Does Hologic stock pay dividends?

No, Hologic (HOLX) stock does not pay dividends to its shareholders as of November 21, 2024.

When is the next Hologic dividend payment date?

Hologic (HOLX) stock does not pay dividends to its shareholders.

What is the beta indicator for Hologic?

Hologic (HOLX) has a beta rating of 0.98. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.